- Direct Data Submission (DDS) Resources
- Preliminary Clinical Quality Measure Results
- Technical Questions
- Adolescent Mental Health /Depression Screening
- Asthma
- Colorectal Cancer Screening
- Depression
- Diabetes & Vascular
- General Measure Question
- HEDIS Questions
- Insurance and RELC supplemental data
- Orthopedic Measures
- Oncology Measures
Oncology Measures - Symptom Control During Chemotherapy
MNCM will restart data collection for the oncology measures known as Symptom Control During Chemotherapy (SCDC) for Measurement Year/Dates of Service 2022 (reported in 2023).
***The timeline for calculating these measures in 2023 is to be determined. Groups can continue to build the file extracts. We will post new information as it becomes available. Please check back again.
Data collection will be through MNCM’s Process Intelligence Performance Engine (PIPE) system; this will not be collected through MNCM's Direct Data Submission (DDS) process.
Please refer to the PIPE Data Field Specifications for instructions about data submission. Additional documents are attached below (e.g., measure background, measure calculation information).